Affordable Access

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors
  • And 1 more
Type
Published Article
Journal
The Lancet
1474-547X
Publisher
Elsevier
Publication Date
Volume
368
Issue
9538
Pages
843–854
Identifiers
PMID: 16950362
Source
Medline
License
Unknown

Abstract

Altered fractionated radiotherapy improves survival in patients with head and neck squamous cell carcinoma. Comparison of the different types of altered radiotherapy suggests that hyperfractionation has the greatest benefit.

Statistics

Seen <100 times